menu
Your Cart

ITA6354

ITA6354-3
ITA6354-1
ITA6354-2
ITA6354-3
ITA6354-1
ITA6354-2
ITA6354
  • Catalog: ITA6354
  • Gene/Protein: TNFRSF10C
  • Product Description: Immunotag™ TNFRSF10C Antibody
385.0000
Price in reward points: 385

Available Options

Immunotag™ TNFRSF10C Antibody
Antibody Specification
Datasheet

Target Protein TNFRSF10C
Clonality Polyclonal
Storage/Stability -20°C/1 year
Application WB,IHC,ELISA
Recommended Dilution WB 1:500-1:2000 IHC 1:50-1:200
Concentration 1 mg/ml
Reactive Species Human,Rat
Host Species Rabbit
Immunogen A synthesized peptide derived from human TNFRSF10C
Specificity TNFRSF10C Antibody detects endogenous levels of total TNFRSF10C
Purification The antiserum was purified by peptide affinity chromatography.
Form Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt
Gene Name TNFRSF10C
Accession No. O14798
Alternate Names Antagonist decoy receptor for TRAIL/Apo 2L; CD263; Cytotoxic TRAIL receptor 3; DCR1; DCR1 TNFR; Decoy Receptor 1; Decoy TRAIL receptor without death domain; LIT; Lymphocyte inhibitor of TRAIL; MGC149501; MGC149502; TNF related apoptosis inducing ligand receptor 3; TNF-re ated apoptosis inducing ligand receptor 3; TNFRSF10C; TRAIL R3; TRAIL receptor 3; TRAILR3; TRID; Tumor necrosis factor receptor superfamily member 10C; Tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain;
Description Receptor for the cytotoxic ligand TRAIL. Lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. May protect cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand.
Cell Pathway/ Category Primary Polyclonal Antibody
Protein MW 27kDa
Usage For Research Use Only! Not for diagnostic or therapeutic procedures.
Material Safety Data Sheet
English_US
Danish
Dutch
English_UK
French
German
Spanish
Norwegian
Portuguese
Finnish
Swedish
Polish

Write a review

Note: HTML is not translated!
Bad Good
Captcha

CONNECT WITH US